At KBI Biopharma, we advance science and accelerate breakthroughs. As a global leader in biopharmaceutical development and manufacturing, we empower life science companies to bring new medicines and vaccines to the world faster. Explore your potential at KBI, where innovation meets impact.
Position Summary:
KBI Biopharma seeks a highly skilled, motivated analytical scientist to join our Characterization Services team in Louisville, CO. This role is ideal for an experienced scientist with expertise in protein analytics using LC-MS. You will serve as part of a collaborative team of scientists, performing analytical testing by various chromatographic techniques for proteins in early development through commercialization. This position requires a team player with a strong work ethic, ability to pivot with changing priorities, and curiosity and creativity to solve complex problems alongside peers.
Responsibilities:
- Demonstrate expertise in LC-MS, HPLC/UPLC, and other common analytical techniques
- Provide method development support in addition to adhering to established methods for client programs
- Execute analytical experiments in support of product development and regulatory submissions
- Generate high-quality documentation of experiments suitable for publication and regulatory review
- Perform peer reviews of data documented in ELNs and reports
- Glycan characterization experience is preferred but not required
Requirements
For Scientist I:
BS, MS, or Ph.D. in Biophysics, Biochemistry, Analytical Chemistry, Biochemical Engineering
- BS with 7 years of relevant experience
- MS with 5 years of relevant experience
- Ph.D. with relevant experience
- Excellent communication skills and ability to present complex data to diverse audiences
- Proficiency in scientific software and data analysis tools
- Ability to work independently and collaboratively in a fast-paced environment
Salary:
For Scientist I: $85,000-$115,000
For Scientist II: $100,000-$125,000
KBI Biopharma, Inc. is an EEO/AA employer and actively seeks to diversify its work force. Therefore, all qualified applicants, regardless of race, color, national origin, religion, gender, gender identity, sexual orientation, age, disability or veteran status, are strongly encouraged to apply.
I understand that neither the completion of this application nor any other part of my consideration for employment establishes any obligation for KBI Biopharma, Inc. to hire me. If I am hired, I understand that either KBI Biopharma, Inc. or I can terminate my employment at any time and for any reason, with or without cause and without prior notice. I understand that no representative of KBI Biopharma, Inc. has the authority to make any assurance to the contrary.
I attest with my signature below that I have given to KBI Biopharma, Inc. true and complete information on this application. No requested information has been concealed. I authorize KBI Biopharma, Inc. to contact references provided for employment reference checks. If any information I have provided is untrue, or if I have concealed material information, I understand that this will constitute cause for the denial of employment or immediate dismissal.
As the icon of next-generation CDMOs, KBI Biopharma is driving breakthroughs in biopharmaceutical development and manufacturing that positively impact the lives of patients worldwide.
While KBI Biopharma serves a social purpose at its core, we recognize that there is also a need to take broader responsibility for the impacts of our business activities. To this end, we have aligned with our parent company, JSR Life Sciences’, Sustainability program in our focus and approach to Sustainability.
From an environmental standpoint, we’ve adopted a strategy of “Measure. Minimize. Mitigate.” and our approach is simple: No impactful change is too big to tackle or too small to dismiss. We want to accurately measure and drastically minimize our footprint through the adoption of energy-efficient technologies and processes, waste reduction, and conservation of natural resources and have set ambitious targets to do so.